|
Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors
RECRUITINGN/ASponsored by University Hospital Ostrava
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital Ostrava
Started2022-01-01
Est. completion2024-12
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06457438
Summary
In this study, the researchers want to focus on the prevalence of anti-HEV antibodies by a new generation test, direct detection of HEV RNA, and its genotypic analysis in a group of human tissue and cell donors.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: \- patients indicated for organ or cell donation Exclusion Criteria: \- none
Conditions2
Hepatitis ELiver Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital Ostrava
Started2022-01-01
Est. completion2024-12
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06457438